✦ LIBER ✦

Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin

✍ Scribed by Alistair N. Lumb; Ian W. Gallen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of a Prediabetes Case With th

✍ Johnson, J. L.; O'Neal, K. S.; Pack, C. C.; Kim, M. K. 📂 Article 📅 2014 🏛 Harvey Whitney Books Company 🌐 English ⚖ 289 KB

Sitagliptin phosphate: A DPP-4 inhibitor

✍ Tina Zerilli; Eunice Y. Pyon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Sitagliptin, a DPP-4 inhibitor for the t

✍ Karasik, Avraham; Aschner, Pablo; Katzeff, Harvey; Davies, Michael J.; Stein, Pe 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 462 KB

Pharmacokinetics and Pharmacodynamic Eff

✍ Herman, G. A. 📂 Article 📅 2006 🏛 Sage Publications 🌐 English ⚖ 377 KB

Tu1037 Dipeptidyl Peptidase- 4 (Dpp-4) I

✍ Tomeno, Wataru; Yoneda, Masato; Imajo, Kento; Mawatari, Hironori; Kirikoshi, Hir 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

The oral DPP-4 inhibitor linagliptin sig

✍ T. Forst; B. Uhlig-Laske; A. Ring; A. Ritzhaupt; U. Graefe-Mody; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB